K.J. Harrison & Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
+13,596
New +$1.3M 0.19% 116
2025
Q4
Sell
-16,620
Closed -$1.59M 240
2025
Q3
$1.59M Buy
+16,620
New +$1.53M 0.23% 108
2024
Q1
Sell
-4,800
Closed -$395K 214
2023
Q4
$395K Buy
+4,800
New +$366K 0.07% 172
2023
Q3
Sell
-12,300
Closed -$1.08M 171
2023
Q2
$1.08M Buy
+12,300
New +$1.06M 0.2% 120
2023
Q1
Sell
-2,000
Closed -$211K 261
2022
Q4
$211K Buy
+2,000
New +$162K 0.04% 194
2022
Q1
Sell
-4,100
Closed -$425K 357
2021
Q4
$425K Buy
+4,100
New +$475K 0.06% 206
2020
Q4
Sell
-6,000
Closed -$624K 299
2020
Q3
$624K Buy
+6,000
New +$603K 0.13% 153

Other funds holding MDT

K.J. Harrison & Partners's MDT Position: Q1 2026 in Review

K.J. Harrison & Partners opened a new position in Medtronic (MDT) in Q1 2026: 13,596 shares worth $1.18M. The stake represents 0.19% of the portfolio and ranks #116 among its holdings. This is a return to the name: K.J. Harrison & Partners previously reported a position in MDT as recently as Q3 2025.

K.J. Harrison & Partners first reported a position in MDT in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.59M in Q3 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • K.J. Harrison & Partners held 13,596 shares of Medtronic worth $1.18M as of Q1 2026.
  • Medtronic was a new K.J. Harrison & Partners position in Q1 2026.
  • Medtronic made up 0.19% of K.J. Harrison & Partners's portfolio in Q1 2026, its #116 holding.
  • K.J. Harrison & Partners first reported a position in Medtronic in Q3 2020 and has held it in 7 quarters since.
  • K.J. Harrison & Partners's Medtronic position peaked at $1.59M in Q3 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.